MEDLEY PHARMACEUTICALS LIMITED

Form 483 issued May 19, 2023 · KACHIGAM, India

Inspection
May 15 – May 19, 2023
Investigator
Teresa I. Navas
Observations
5
Pages
7
FEI number
3006896204

In short: On May 19, 2023, FDA issued a Form 483 with 5 observations to MEDLEY PHARMACEUTICALS LIMITED in KACHIGAM, DAMAN (FEI 3006896204) after an inspection that ran May 15 – May 19, 2023. The investigator was Teresa I. Navas. Most observations concern production and facilities & equipment.

At a glance

Production and facilities & equipment account for 4 of 5 observations.

Production2
Facilities & equipment2
Quality system1

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    There is a failure to thoroughly review any unexplained discrepancy whether or not the batch…

  2. 02

    Control procedures are not established which monitor the output and validate the performance of those manufacturing…

  3. 03

    Equipment and utensils are not cleaned at appropriate intervals to prevent contamination that would alter the…

  4. 04

    Equipment for adequate control over humidity and temperature is not provided when appropriate for the manufacture…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at MEDLEY PHARMACEUTICALS LIMITED?

FDA listed 5 observations on this Form 483, mostly about production, facilities & equipment and quality system. The opening words of each observation are shown on this page.

Who inspected MEDLEY PHARMACEUTICALS LIMITED?

Teresa I. Navas is named on this Form 483, for the inspection of May 15 – May 19, 2023. Each investigator has a profile showing what they cite most.

When was MEDLEY PHARMACEUTICALS LIMITED inspected by FDA?

The inspection ran May 15 – May 19, 2023, and the Form 483 is dated May 19, 2023.

How do I get the full Form 483 for MEDLEY PHARMACEUTICALS LIMITED?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free